All In Biotech

Free tool

FAERS Monitor: Zithromax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050711 or its brand name (Zithromax, Azithromycin). Reports on generic versions are filed under their own applications.

Reports

19,146

Serious

13,050

68% of reports

Hospitalization

6,476

Death reported

1,467

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity1,997
  • dyspnoea1,466
  • drug ineffective1,199
  • nausea1,133
  • pain1,088
  • diarrhoea1,040
  • off label use1,014
  • fatigue1,013
  • pneumonia990
  • headache951
  • cough917
  • anxiety883
  • vomiting843
  • pyrexia842
  • rash745

Reports by year received

View as table
YearReports
2004585
2005655
2006627
2007381
2008456
2009562
2010951
2011927
20121,059
2013740
2014905
20151,130
20161,333
20171,066
20181,335
20191,273
20201,191
2021904
2022774
2023716
2024639
2025545
2026392

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,013 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal1,99711.411.019,002
coughSignal9173.63.41,737
anxietySignal8833.43.21,522
pneumoniaSignal9903.43.21,665
dyspnoeaSignal1,4662.82.71,802
pyrexiaSignal8422.72.5896
vomiting8432.01.8411
pain1,0881.91.8515
rash7451.91.8311
diarrhoea1,0401.81.7359
headache9511.71.6261
nausea1,1331.61.5245
fatigue1,0131.41.3135
off label use1,0141.31.261
drug ineffective1,1991.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.